131 related articles for article (PubMed ID: 26892647)
1. Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.
Kovacevic L; Lu H; Caruso JA; Lakshmanan Y
Urology; 2016 Jun; 92():100-5. PubMed ID: 26892647
[TBL] [Abstract][Full Text] [Related]
2. Urinary proteomics reveals association between pediatric nephrolithiasis and cardiovascular disease.
Kovacevic L; Lu H; Caruso JA; Kovacevic N; Lakshmanan Y
Int Urol Nephrol; 2018 Nov; 50(11):1949-1954. PubMed ID: 30209738
[TBL] [Abstract][Full Text] [Related]
3. Urine proteomic analysis in cystinuric children with renal stones.
Kovacevic L; Lu H; Goldfarb DS; Lakshmanan Y; Caruso JA
J Pediatr Urol; 2015 Aug; 11(4):217.e1-6. PubMed ID: 26076823
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C, Neutrophil Gelatinase-associated Lipocalin, and Lysozyme C: Urinary Biomarkers for Detection of Early Kidney Dysfunction in Children With Urolithiasis.
Kovacevic L; Lu H; Kovacevic N; Thomas R; Lakshmanan Y
Urology; 2020 Sep; 143():221-226. PubMed ID: 32505622
[TBL] [Abstract][Full Text] [Related]
5. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
[TBL] [Abstract][Full Text] [Related]
6. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of inhibitory protein profiles in the urine of children with nephrolithiasis: implication for disease prevention.
Kovacevic L; Kovacevic N; Lakshmanan Y
Int Urol Nephrol; 2022 Nov; 54(11):2783-2788. PubMed ID: 35879498
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
Ma MC; Chen YS; Huang HS
Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
[TBL] [Abstract][Full Text] [Related]
9. Tubular proteinuria in renal calcium stone formers.
Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S
Ups J Med Sci; 1985; 90(1):25-30. PubMed ID: 3890317
[TBL] [Abstract][Full Text] [Related]
10. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P
Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439
[TBL] [Abstract][Full Text] [Related]
11. Urine proteomic profiling in patients with nephrolithiasis and cystinuria.
Kovacevic L; Caruso JA; Lu H; Kovacevic N; Lakshmanan Y; Carruthers NJ; Goldfarb DS
Int Urol Nephrol; 2019 Apr; 51(4):593-599. PubMed ID: 30519981
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis.
Böhles H; Gebhardt B; Beeg T; Sewell AC; Solem E; Posselt G
J Pediatr; 2002 Jan; 140(1):103-9. PubMed ID: 11815772
[TBL] [Abstract][Full Text] [Related]
13. Phosphate metabolism and renal calcium stone disease.
Wikström B
Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi.
Boonla C; Tosukhowong P; Spittau B; Schlosser A; Pimratana C; Krieglstein K
Clin Chim Acta; 2014 Feb; 429():81-9. PubMed ID: 24333391
[TBL] [Abstract][Full Text] [Related]
15. [Tubular dysfunction in renal lithiasis: cause or consequence?].
Jaeger P; Portmann L; Burckhardt P
Schweiz Med Wochenschr; 1985 Feb; 115(5):160-2. PubMed ID: 2858124
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical importance of renal tubular defects in recurrent renal stone formers.
Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
Nephron; 1980; 25(2):96-101. PubMed ID: 6243755
[TBL] [Abstract][Full Text] [Related]
17. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis.
Reinhart SC; Norden AG; Lapsley M; Thakker RV; Pang J; Moses AM; Frymoyer PA; Favus MJ; Hoepner JA; Scheinman SJ
J Am Soc Nephrol; 1995 Jan; 5(7):1451-61. PubMed ID: 7703383
[TBL] [Abstract][Full Text] [Related]
18. Tubular defects in patients forming calcium-containing stones.
Backman U
Eur Urol; 1978; 4(1):50-6. PubMed ID: 342251
[TBL] [Abstract][Full Text] [Related]
19. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
[TBL] [Abstract][Full Text] [Related]
20. Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function.
Sutton RA; Walker VR
N Engl J Med; 1980 Mar; 302(13):709-13. PubMed ID: 7354777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
